论文部分内容阅读
目的观察舒马曲坦与头痛宁联合治疗偏头痛的有效性和安全性。方法将73例偏头痛患者随机分为2组,观察组37例采用皮下注射舒马曲坦与口服步长头痛宁胶囊相结合,对照组36例口服西比灵,对比两组疗效及复发率。结果观察组患者头痛发作次数减少、发作时间缩短和程度减轻,复发率降低,与对照组比较差异具有统计学意义。结论舒马曲坦与头痛宁联合治疗偏头痛标本兼治,疗效确切,安全性好。
Objective To observe the efficacy and safety of sumatriptan combined with Tountain in the treatment of migraine. Methods Seventy-three migraineurs were randomly divided into two groups. In the observation group, 37 cases were treated with subcutaneous injection of sumatriptan and oral step-head capsule. In the control group, 36 cases were given cisaparin. The curative effect and relapse rate were compared between the two groups . Results In the observation group, the number of headache attacks decreased, the attack time shortened and the degree of remission decreased, and the recurrence rate decreased. The difference was statistically significant compared with the control group. Conclusion Sumatriptan combined with headache Ning treatment of migraine symptoms, curative effect is exact, good safety.